Legis Daily

End Taxpayer Funding of Gender Experimentation Act of 2021

USA117th CongressS-777| Senate 
| Updated: 3/16/2021
Roger Marshall

Roger Marshall

Republican Senator

Kansas

Cosponsors (7)
Mike Braun (Republican)Cindy Hyde-Smith (Republican)Mike Lee (Republican)Marsha Blackburn (Republican)Tom Cotton (Republican)Roger F. Wicker (Republican)Steve Daines (Republican)

Finance Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
End Taxpayer Funding of Gender Experimentation Act of 2021 This bill modifies provisions relating to federal funding for, and health insurance coverage of, gender reassignment medical interventions, which include surgical remedies and hormone therapy arising from a conflict between an individual's gender identity and the sex the individual has or was identified as having at birth. Specifically, the bill prohibits the use of federal funds for gender reassignment medical interventions or for health coverage that includes such interventions. Additionally, such interventions may not be provided in a federal health care facility or by a federal employee. Under current law, coverage of these interventions through Medicare and Medicaid is generally determined at the state level. The bill's restrictions regarding the use of federal funds do not apply to treatment of individuals with medically verifiable disorders of sex development, such as individuals born with atypical development of chromosomal, gonadal, or anatomical sex. The bill also prohibits qualified health plans from including coverage for gender reassignment medical interventions. Further, plans that include coverage for such interventions are not eligible for federal subsidies.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 16, 2021
Introduced in Senate
Mar 16, 2021
Read twice and referred to the Committee on Finance.
May 18, 2021

Latest Companion Bill Action

HR 117-1927
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
  • March 16, 2021
    Introduced in Senate


  • March 16, 2021
    Read twice and referred to the Committee on Finance.


  • May 18, 2021

    Latest Companion Bill Action

    HR 117-1927
    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Health

Related Bills

  • HR 117-1927: End Taxpayer Funding of Gender Experimentation Act of 2021
  • HR 117-8731: Protect Children’s Innocence Act
AppropriationsComprehensive health careDrug therapyEmployee benefits and pensionsGovernment buildings, facilities, and propertyGovernment employee pay, benefits, personnel managementHealth care costs and insuranceHealth care coverage and accessHealth facilities and institutionsHealth personnelHealth programs administration and fundingIncome tax creditsSex and reproductive healthSmall businessSurgery and anesthesia

End Taxpayer Funding of Gender Experimentation Act of 2021

USA117th CongressS-777| Senate 
| Updated: 3/16/2021
End Taxpayer Funding of Gender Experimentation Act of 2021 This bill modifies provisions relating to federal funding for, and health insurance coverage of, gender reassignment medical interventions, which include surgical remedies and hormone therapy arising from a conflict between an individual's gender identity and the sex the individual has or was identified as having at birth. Specifically, the bill prohibits the use of federal funds for gender reassignment medical interventions or for health coverage that includes such interventions. Additionally, such interventions may not be provided in a federal health care facility or by a federal employee. Under current law, coverage of these interventions through Medicare and Medicaid is generally determined at the state level. The bill's restrictions regarding the use of federal funds do not apply to treatment of individuals with medically verifiable disorders of sex development, such as individuals born with atypical development of chromosomal, gonadal, or anatomical sex. The bill also prohibits qualified health plans from including coverage for gender reassignment medical interventions. Further, plans that include coverage for such interventions are not eligible for federal subsidies.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 16, 2021
Introduced in Senate
Mar 16, 2021
Read twice and referred to the Committee on Finance.
May 18, 2021

Latest Companion Bill Action

HR 117-1927
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
  • March 16, 2021
    Introduced in Senate


  • March 16, 2021
    Read twice and referred to the Committee on Finance.


  • May 18, 2021

    Latest Companion Bill Action

    HR 117-1927
    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Roger Marshall

Roger Marshall

Republican Senator

Kansas

Cosponsors (7)
Mike Braun (Republican)Cindy Hyde-Smith (Republican)Mike Lee (Republican)Marsha Blackburn (Republican)Tom Cotton (Republican)Roger F. Wicker (Republican)Steve Daines (Republican)

Finance Committee

Health

Related Bills

  • HR 117-1927: End Taxpayer Funding of Gender Experimentation Act of 2021
  • HR 117-8731: Protect Children’s Innocence Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
AppropriationsComprehensive health careDrug therapyEmployee benefits and pensionsGovernment buildings, facilities, and propertyGovernment employee pay, benefits, personnel managementHealth care costs and insuranceHealth care coverage and accessHealth facilities and institutionsHealth personnelHealth programs administration and fundingIncome tax creditsSex and reproductive healthSmall businessSurgery and anesthesia